Current clinical trials
Currently Recruiting Clinical Trials
Check links below for more information and eligibility criteria for individual trials.
Breast Cancer
REDISCOVER
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer (ReDiscover-2)
https://clinicaltrials.gov/study/NCT06982521
VIKTORIA-2
A Randomized, Open-Label, Phase 3 Study of Fulvestrant and CDK4/6 Inhibitors With or Without Gedatolisib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer
https://clinicaltrials.gov/study/NCT06757634
Germ Cell Cancer
P3BEP
Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for participants with intermediate and poor risk metastatic germ cell tumours
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000496718
OVARIAN CANCER
MEN2501-01
A Phase 1, First-In-Human Study Of Men2501, A Kif18a Inhibitor, As Monotherapy In Participants With Platinum-Resistant Ovarian Cancer
https://clinicaltrials.gov/study/NCT07226427
Prostate Cancer
WOMBAT
Working Out M0 Bipolar Androgen Therapy (WOMBAT)
https://clinicaltrials.gov/study/NCT06594926
Bladder Cancer
LEGEND
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) and High-Risk NMIBC Patients who are BCG Naïve or Received Incomplete BCG Treatment
https://clinicaltrials.gov/study/NCT04752722
Multiple cancers
CONTEXT
A Phase 1a/1b, First-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants with Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
https://clinicaltrials.gov/study/NCT07545122
YF-N01-002
A Phase I/II Clinical Study Evaluating the Safety, Tolerability, and Efficacy of N-3C01 as Monotherapy and in Combination with PD-(L)1 Monoclonal Antibody in Patients with Advanced Malignant Solid Tumors
https://clinicaltrials.gov/study/NCT07639450
Cancer - Peripheral Neuropathy
INFOCUS
Peripheral Neuropathy in Chemotherapy-treated Patients: Predictors, Assessment strategies and Functional Outcomes: IN FOCUS (Identifying Neurological and Functional Outcomes in Cancer Survivors Study)
Kidney Disease / Renal
PYC-003-CL-001
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Administered PYC-003, a Peptide-phosphorodiamidate Morpholino Oligonucleotide Conjugate, in Healthy Adult Participants and Adult Participants With Confirmed PKD1 Mutation-associated Autosomal Dominant Polycystic Kidney Disease
https://clinicaltrials.gov/study/NCT06714006
POSIBIL6ESKD
A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis
https://clinicaltrials.gov/study/NCT05485961
RESOLVE
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Menopause
ADELE
A real-world observational study describing sleep outcomes among women with vasomotor symptoms associated with menopause using fezolinetant in Australia
CROHNS DISEASE
SIBERITE-2
A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study To Assess The Efficacy And Safety Of Induction Therapy With Ro7790121 In Patients With Moderately To Severely Active Crohn's Disease
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=23916&isClinicalTrial=True
VECTOR
An Interventional Study to Evaluate Treating to a Target of Transmural Healing in Patients with Moderately to Severely Active Crohn’s Disease (VECTORS)
https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=22584&isClinicalTrial=True